Fundraising Fox

Mark Feitelson

Founder

Founder at SFA Therapeutics

Philadelphia, Pennsylvania, United States

FoundedSFA Therapeutics · YC

About

Mark Feitelson holds a Ph.D. in Microbiology/Immunology from UCLA and has conducted research on hepatitis B at Stanford University and Fox Chase Cancer Center before joining Temple University as a Professor of Biology. He serves as Chief Scientific Officer of SFA Therapeutics.

Founder at SFA TherapeuticsYC S21

Intro paths

YC

Mark went through Y Combinator (Summer 2021) — any YC alum in your network can reach them through the YC community.

In turn, Mark can intro founders to SFA Therapeutics's investors below.

Co-founders at SFA Therapeutics

ISIra Spector

Experience

  1. Temple UniversityProfessorcurrent2007 — present
  2. Thomas Jefferson UniversityProfessor of Pathology, Anatomy and Cell Biology1991 — 2007
  3. Fox Chase Cancer CenterAssociate Member1982 — 1991Greater Philadelphia Area
  4. Stanford University School of MedicineAmerican Cancer Society Postdoctoral Fellow1979 — 1982Palo Alto, California

Education

  1. David Geffen School of Medicine at UCLAPh.D., microbiology and immunology (virology)1974 — 1979
  2. David Geffen School of Medicine at UCLAPh.D., Microbiology and Immunology1974 — 1979

Skills & more

Molecular Biology12Cell Biology25Cancer23Virology4Cancer Research11Animal Models3Immunohistochemistry2Microbiology6Clinical Research3Biotechnology19Teaching1Research6
+12 moreOncologyTranslational ResearchWestern BlottingBiomarkersPCRCell CultureHigher EducationElectrophoresisIn VivoScienceBiomarker DiscoveryImmunology

From Mark's professional profile.

Founder mafias

Same school

Shared employers